Small-cap stocks have taken a beating this year. Since many of them are pre-profit or marginally profitable, risk-averse investors have shied away fro...
Potential Triple Digit Gains, New Report Coming 10-27-22 Near Market Open. A Float so Small it’s Nearly Non-Existent, Very Big Names Involved and Trading Under .60/Share
New Report Coming Tomorrow on a Ground Floor Opportunity in a Company That Investors and Tech Gurus Are Flocking To A Float so Small it’s Nearly Non-E...
Small Cap Biotech’s and Recent IPO’s Are Still Rewarding Investors and Traders Alike
Small cap investors like to take risks because the rewards can be higher than those generated by large cap company investments. That said, this risk-t...
Try to Have a Good Weekend Breakout Group! Market Turmoil Continues…
We will be back on Sunday with updates…
TNS Reports, These Four Stocks have New Developments that Could Equate to Big Catalysts
The Timing Looks Perfect for our New Featured Stock Report Given the Current Environment (coming Oct. 5, 2022) Traders News Source is currently prepar...
BREAKING NEWS STORY UPDATED 10/03/2022 12:58 PM EDT: Why is the Federal Reserve Holding an Expedited Meeting on Monday October 3rd, 2022 at 11:30 AM EDT?
It is anticipated that the closed meeting of the Board of Governors of the Federal Reserve System at 11:30 a.m. on Monday, October 3, 2022, will be he...
TNS Reports on Stocks with Near Term Catalysts in the Works
The Timing Looks Perfect for our New Featured Stock Report Given the Current Environment (coming Oct. 5, 2022) Traders News Source is currently prepar...
There has Been A Lot of Chatter on Social Media About Identifying a New Meme Stock, Does the Equities Market Just Need a New Meme Stock to Give it Legs?
There has Been a Lot of Chatter on Social About Identifying a New Meme Stock, Maybe the Equities Market Just Needs a New Meme Stock to Give it Legs &n...
Stem Cell Therapies Are a Hot Biopharma Sector and Investors May Want to Look at These Players
Stem cell regenerative therapies, for a variety of indications, are at the leading edge of biopharma technology. The science in stem cell research has...
We will be back with a tiny float NASDAQ trading at 1/3 book value. Report coming Monday 9-26-22 at or near market open.
The Cloud Over the Equities Market Has a Silver Lining as it Exposes Some Irresistible Values New report coming Monday, September 26,2022, at or near ...
